Acidic Conditions Make Pancreatic Cancer More Resilient

Buildup of acidic byproducts in pancreatic tumors alleviates the effects of other environmental stresses and aids the cancer.

Written byAndrea Lius, PhD
| 2 min read
A cartoon tumor cell with a monster-like face flexes its biceps, representing cancer’s resilience against different types of stress.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When life gives cancer lemons, it says “thank you.”

Scientists recently discovered that in pancreatic tumors, acidic conditions made cells more resistant to other types of stressors, such as nutrient deprivation.1 Their results, published in Science, provide new insights into how tumor cells rise above harsh conditions and may guide researchers’ efforts in overcoming cancer’s resilience.

“It changes the way we think about tumor metabolism,” said Wilhelm Palm, a cancer biologist at the German Cancer Research Center and a coauthor of the study, in a statement. “Acidosis is not just a byproduct of altered metabolism in tumors. It’s a dominant factor that shapes energy metabolism in cancer cells and makes them resilient to different types of stress.”

Cancer cells go through a lot just to survive. Tumors are often poorly oxygenated and low in nutrients, so cancer cells often rewire their metabolism to thrive in these conditions. One of these adaptations, the Warburg effect, drives cells to metabolize glucose via glycolysis, which causes lactic acid to accumulate. The buildup of acidic byproducts from metabolism, called acidosis, can in turn produce more stress for cancer cells.

Many researchers who study how cancer cells withstand stress typically investigate these stressors independently. But in the body, tumor cells often encounter different types of stress simultaneously.

Aiming to understand this complexity better, Palm collaborated with Johannes Zuber, a cancer geneticist at the Research Institute of Molecular Pathology. First, the researchers wanted to identify the genes that help cancer cells withstand common types of stress in tumors—called fitness genes. They performed a genome-wide CRISPR-Cas9 knockout screen in pancreatic cancer cells and discovered hundreds of fitness genes.

Continue reading below...

Like this story? Sign up for FREE Genetics updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

To validate their findings in vivo, the researchers repeated the screen in a xenograft mouse model. Results from the in vivo screen revealed that under stress, the tumor cells shifted their metabolism to depend more on mitochondrial oxidative respiration than cytoplasmic glycolysis.

By comparing their in vitro and in vivo models, the team discovered that the addition of lactic acid to cells in culture recapitulated the effects that various stresses had on tumors. This suggested that acidosis is likely a key stressor that can reshape cancer cell metabolism.

To test this hypothesis, the researchers exposed pancreatic cancer cells to acidosis, alone or in combination with another stressor, such as glucose deprivation. Subjecting cells to both acidosis and glucose deprivation abolished the latter’s effects, indicating that acidosis could indeed make tumor cells more resilient to other stressors. On the other hand, when the team paired glucose deprivation with hypoxia, they observed an additive effect due to both stressors.

“This discovery is highly relevant for our search for more effective cancer therapies,” said Zuber. “With [this] knowledge, we can now search for therapies under these more realistic conditions and explore new ways to break this resilience.”

  1. Groessl S, et al. Acidosis orchestrates adaptations of energy metabolism in tumors. Science. 2025;390(6769):eadp7603.

Related Topics

Meet the Author

  • Image of Andrea Lius.

    Andrea Lius is an intern at The Scientist. She earned her PhD in pharmacology from the University of Washington. Besides science, she also enjoys writing short-form creative nonfiction.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies